What if you'd held FTXH?
A $1,000 investment in First Trust Nasdaq Pharmaceuticals ETF (FTXH) at the month-end close of 2016-09 would be worth $2,448 at the close of 2026-08 — +144.8% total return, dividends reinvested. The same $1,000 in the S&P 500 would be worth $3,555.
Your scenario
Result
If you'd bought $1,000 at the start of each year
Value of $1,000 invested on January 1 of each year, held to 2026-08, dividends included.
Every year, $1,000 from 2016
| Year | Value of $1,000 | Year return |
|---|---|---|
| 2016 | $1,000 | — |
| 2017 | $1,194 | +19.4% |
| 2018 | $1,081 | -9.5% |
| 2019 | $1,320 | +22.1% |
| 2020 | $1,475 | +11.7% |
| 2021 | $1,566 | +6.1% |
| 2022 | $1,606 | +2.6% |
| 2023 | $1,583 | -1.4% |
| 2024 | $1,630 | +3.0% |
| 2025 | $2,023 | +24.1% |
| 2026 | $2,628 | +29.9% |
Best and worst month-end to buy
The best single month-end close to have bought FTXH was 2016-10 ($15.97): $1,000 then is $2,668 today. The worst was 2026-08 ($42.60): $1,000 then is $1,000.
FAQ
What would $1,000 in FTXH be worth today?
A $1,000 investment in First Trust Nasdaq Pharmaceuticals ETF (FTXH) at the start of 2016 would be worth about $2,448 today, a total return of +144.8%. Dividends are reinvested in these figures.
What were the best and worst years for FTXH?
First Trust Nasdaq Pharmaceuticals ETF (FTXH)'s strongest calendar year since 2016 was 2026, a +29.9% return — $1,000 held through that year became about $1,299 by year-end. Its weakest year was 2018, at -9.5%.
Does the calculator include dividends and splits?
Yes where available. Prices are adjusted for both stock splits and reinvested dividends (total return), the same measure brokerages use.
How much would $100 per month in FTXH have grown?
Investing $100 at the end of every month since 2016-09 would have grown to about $22,456 on $12,000 invested.
Did FTXH beat the S&P 500?
Over the same period, $1,000 in the S&P 500 index would be worth $3,555. FTXH trailed the S&P 500 by +31.1% in total return.
Is this investment advice?
No. Wall Street Regrets is an entertainment and education tool. Every number is a historical calculation, not a prediction, and past performance never guarantees future results.
Methodology
First Trust Nasdaq Pharmaceuticals ETF (FTXH) historical total-return data from 2016-09 to 2026-08, reduced to month-end closes for the tables above.
Returns use adjusted close prices from Yahoo Finance historical data — adjusted for stock splits and reinvested dividends — the same convention used by major brokerages. A "year" scenario invests $1,000 at the prior December's month-end close and values it at the latest available month-end close. Non-USD amounts are converted at historical month-end exchange rates (Yahoo Finance): to USD on the buy date and back to your currency at the latest rate, so the return reflects the currency move as well as the asset.
Month-end resolution means intra-month extremes are not captured in tables; the calculator uses exact trading-day closes where daily data is available. Figures ignore taxes, fees, and the currency effects of non-USD listings. History is not a forecast. Wall Street Regrets is entertainment, not investment advice.
What if you'd held…
Data: adjusted close prices via Yahoo Finance. As of 2026-08. Not financial advice.